Advanced search
Publication Cover
International Journal of Endocrine Oncology Volume 7, 2020 - Issue 3
Journal homepage
1,148
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Recurrence-Free Survival Following Aggressive Multimodal Treatment of an Isolated Recurrence of Adrenocortical Carcinoma

Alexander Magony1 Schulich School of Medicine, Western University, London, Ontario N6A 5C1, Canada;2 Division of General Internal Medicine, Department of Medicine, University of Toronto, Toronto, Ontario M5S 3H2, CanadaORCID Iconhttps://orcid.org/0000-0003-2209-1858
ORCID Icon,
Adam Mutsaers3 Department of Radiation Oncology, London Regional Cancer Program, London, Ontario N6A 5W9, CanadaORCID Iconhttps://orcid.org/0000-0002-2185-6874
ORCID Icon &
Belal Ahmad3 Department of Radiation Oncology, London Regional Cancer Program, London, Ontario N6A 5W9, CanadaCorrespondence[email protected]
Article: IJE32 | Received 10 Sep 2020, Accepted 06 Jan 2021, Published online: 31 Mar 2021

References

  • WongKK, MillerBS, VigliantiBL. Molecular imaging in the management of adrenocortical cancer: a systematic review. Clin. Nucl. Med. 41(8), 368–382 (2016).
  • ElseT, WilliamsAR, SabolchA, JollyS, MillerBS, HammerGD. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 99(2), 455–461 (2014).
  • StiglianoA, CerquettiL, LardoP, PetrangeliE, ToscanoV. New insights and future perspectives in the therapeutic strategy of adrenocortical carcinoma (review). Oncol. Rep. 37(3), 1301–1311 (2017).
  • AminiN, MargonisGA, KimY et al. Curative resection of adrenocortical carcinoma: rates and patterns of postoperative recurrence. Ann. Surg. Oncol. 23(1), 126–133 (2016).
  • FassnachtM, KroissM, AllolioB. Update in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 98(12), 4551–4564 (2013).
  • TerzoloM, AngeliA, FassnachtM et al. Adjuvant mitotane treatment for adrenocortical carcinoma. N. Engl. J. Med. 356(23), 2372–2380 (2007).
  • SrougiV, de BassaJJr, TannoFY et al. Adjuvant radiotherapy for the primary treatment of adrenocortical carcinoma: are we offering the best?Int. Braz. J. Urol. 43(5), 841–848 (2017).
  • TranTB, MaithelSK, PawlikTM et al. Clinical score predicting long-term survival after repeat resection for recurrent adrenocortical carcinoma. J. Am. Coll. Surg. 223(6), 794–803 (2016).
  • TiberioGAM, FerrariV, BallariniZ et al. Hyperthermic intraperitoneal chemotherapy for primary or recurrent adrenocortical carcinoma. A single center study. Cancers 12(4), 969 (2020).
  • LaganàM, GrisantiS, CosentiniD et al. Efficacy of the EDP-M scheme plus adjunctive surgery in the management of patients with advanced adrenocortical carcinoma: the Brescia Experience. Cancers 12(4), 941 (2020).
  • GlennJA, ElseT, HughesDT et al. Longitudinal patterns of recurrence in patients with adrenocortical carcinoma. Surgery 165(1), 186–195 (2019).
  • NaingA, Meric-BernstamF, StephenB et al. Phase II study of pembrolizumab in patients with advanced rare cancers. J. Immunother. Cancer 8(1), e000347 (2020).
  • LuoY, ChenSS, ZhengXG, LuoL, WangS. The efficacy of radiation therapy in adrenocortical carcinoma: a propensity score analysis of a population-based study. Medicine (Baltimore). 96(17), 6741 (2017).
  • FassnachtM, HahnerS, PolatB et al. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 91(11), 4501–4504 (2006).
  • HabraMA, EjazS, FengL et al. A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 98(1), 192–197 (2013).
  • FayAP, ElfikyA, TelóGH et al. Adrenocortical carcinoma: the management of metastatic disease. Crit. Rev. Oncol. Hematol. 92(2), 123–132 (2014).
  • PolatB, FassnachtM, PfreundnerL et al. Radiotherapy in adrenocortical carcinoma. Cancer 115(13), 2816–2823 (2009).
  • MilgromSA, GoodmanKA. The role of radiation therapy in the management of adrenal carcinoma and adrenal metastases. J. Surg. Oncol. 106(5), 647–650 (2012).
  • GuptaN, BansaiU, MahajanN, YadavMS. Abdominal wall metastasis in scar after open resection of an adrenocortical carcinoma. Clin. Pract. 2(1), 9 (2012).
  • van GrevensteinWM, de KrijgerRR, de HerderWW, TilanusHW, BonjerHJ. Abdominal wall metastasis after open resection of an adrenocortical carcinoma. Eur. J. Surg. 167(11), 871–873 (2001).
  • BhatkuleMA, DhawleMS, MulayVM, BinduRS. Adrenocortical carcinoma with metastasis in abdominal wall: a rare case report. Clin. Cancer Investig. J. 4(4), 572–574 (2015).
  • MorinE, MeteO, WassermanJD, JoshuaAM, AsaSL, EzzatS. Carney complex with adrenal cortical carcinoma. J. Clin. Endocrinol. Metab. 97(2), 202–206 (2012).
  • FoxiusA, RambouxA, LefebvreY et al. Hazards of laparoscopic adrenalectomy for Conn’s adenoma. When enthusiasm turns to tragedy. Surg. Endosc. 13(7), 715–717 (1999).
  • HamoirE, MeurisseM, DefechereuxT. Is laparascopic resection of a malignant corticoadrenaloma feasible? Case report of early, diffuse and massive peritoneal recurrence after attempted laparoscopic resection. Ann. Chir. 52(4), 364–368 (1998) ( Article title translated from French).
  • MillerBS, GaugerPG, HammerGD, DohertyGM. Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy. Surgery 152(6), 1150–1157 (2012).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.